• Angiotensin I/II (1-5) Workflow Guide

  2026-09-16

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure and aldosterone-related assays. It should be used only in validated cardiovascular or renal workflows, with solvent-matched controls and cautious interpretation because directly matched paper evidence was not available for this product-specific application.

• Agatoxin-IVA and Nicotinic Activation of Vagal Neurons

  2026-09-16

  The reference study showed that agatoxin-IVA-sensitive voltage-dependent calcium channels connect nicotinic receptor activation to both presynaptic glutamate release and postsynaptic excitation in cardiac vagal neurons. Its selective pharmacological design separated Cav2.1/P-type channel involvement from L-, N-, and Q-type channel contributions, providing a useful framework for synaptic transmission research.

• AO/PI Staining Solution for Mechanistic Assays

  2026-09-15

  AO/PI Staining Solution provides fluorescence-based cell counting that separates membrane-intact from membrane-compromised cells. This guide explains how to use dual fluorescent DNA dyes as a quality-control and decision tool in diabetic nephropathy research, rather than treating viability as a standalone endpoint.

• Tamoxifen Workflows for CreER and Disease Models

  2026-09-15

  Learn how Tamoxifen supports temporal gene control, breast cancer research, and mechanistic disease modeling. This workflow-focused guide pairs formulation and induction strategies with insights from a study of recurrent airway inflammation and GZMK-expressing CD8+ T cells.

• ALC-0315 for Reproducible LNP Assays

  2026-09-14

  Learn how ALC-0315 (SKU B8595) can support controlled lipid nanoparticle workflows for cell viability, proliferation, and cytotoxicity studies. This scenario-based guide connects material quality, solvent compatibility, mixing, and batch interpretation with evidence from recent LNP research.

• WAY-100635 for Reliable 5-HT1A Assays

  2026-09-14

  Learn how WAY-100635 (SKU A3933) can strengthen receptor-mechanism controls in cell viability, proliferation, cytotoxicity, and pain-related studies. This scenario-based guide covers formulation, protocol design, interpretation, vendor evaluation, and the limits of translating behavioral findings into cellular assays.

• Fluoxetine HCl: Mechanism and Research Workflows

  2026-09-13

  Fluoxetine HCl is a selective serotonin reuptake inhibitor used to study serotonin transporter activity, 5HT2C signaling, neurogenesis, and reward-related behavior. Its molecular effects are well established, while developmental-exposure findings in mice define a research model rather than a clinical treatment conclusion.

• SB203580: p38 MAPK Assay Workflows

  2026-09-12

  Use SB203580 to separate p38-dependent stress signaling from the MAPK/ERK responses implicated in vascular lipid toxicity. This practical guide covers stock preparation, branch-specific controls, nanoparticle-exposure assays, dose selection, and troubleshooting for reproducible cell-based experiments.

• Everolimus (RAD001) Cancer Assay Workflows

  2026-09-11

  Everolimus (RAD001) turns mTOR pathway biology into measurable changes in cancer-cell growth, survival, and signaling. This workflow emphasizes exposure-aware dosing, time-resolved viability, and orthogonal apoptosis measurements so researchers can distinguish cytostatic effects from true cell killing.

• Mouse Neutrophil Cell Isolation Kit: Assay Design

  2026-09-11

  Discover how the Mouse Neutrophil Cell Isolation Kit supports activation-conscious assay design across bone marrow, blood, and spleen workflows. This guide connects negative selection with practical interpretation of neutrophil-targeted mRNA nanovaccine studies.

• Rotavirus Infection Reprograms Nrf2 Redox Defense

  2026-09-10

  The reference study shows that rotavirus infection produces a biphasic Nrf2 response: an early, redox-sensitive increase is followed by marked Nrf2 depletion and loss of antioxidant transcription. Its mechanistic analysis implicates proteasome-associated, K48-linked ubiquitination rather than canonical Keap1/Cul3-Rbx1 turnover alone, providing a useful framework for studying viral disruption of cellular stress adaptation.

• Phage-Layer Interferometry for Phage Therapy

  2026-09-10

  The reference study introduces phage-layer interferometry (PLI) as a real-time, quantitative platform for selecting therapeutic phages and detecting bacteria. Its ability to separate phage binding from lytic activity, operate in opaque matrices such as baby formula, and support automation addresses several limitations of plaque-based and optical screening assays.

• Verapamil in Hypoxia-Driven Inflammation

  2026-09-09

  Verapamil ((±)-Verapamil) can function as a mechanistic probe in duration-dependent hypoxia assays, helping researchers test whether urothelial inflammation involves a ROS/TXNIP/NLRP3-associated response. This workflow emphasizes matched controls, fresh solvent handling, and cautious interpretation because calcium-channel blockade and P-glycoprotein inhibition can influence results independently of the inflammatory pathway.

• How p38α Inhibitors Promote Dephosphorylation

  2026-09-09

  The reference preprint shows that selected p38α MAP kinase inhibitors can do more than occupy the catalytic pocket: they can also expose the activation-loop phosphothreonine to the WIP1 phosphatase. This dual-action mechanism links inhibitor-bound conformation to kinase deactivation and offers a structure-guided concept for improving potency and target selectivity.

• Redox-Responsive Peptide Coacervates for mRNA Delivery

  2026-09-08

  The reference study introduces HBpep-SS4, a chemically defined peptide coacervate that combines mRNA condensation, structural stabilization, and glutathione-triggered intracellular release within one peptide design. Its ability to encapsulate diverse RNA cargos and support genome editing highlights a mechanistically distinct alternative to conventional lipid-based delivery, while also defining important questions about cell-type dependence, biodistribution, and translational safety.

8000 records 1/534 page Next 12345 下5页 Last page